SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-20-000013
Filing Date
2020-06-05
Accepted
2020-06-05 16:11:38
Documents
14
Period of Report
2020-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kxannualsharehol.htm   iXBRL 8-K 92686
  Complete submission text file 0000875045-20-000013.txt   236388

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20200422.xsd EX-101.SCH 4451
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20200422_cal.xml EX-101.CAL 624
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20200422_def.xml EX-101.DEF 1474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20200422_lab.xml EX-101.LAB 26147
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20200422_pre.xml EX-101.PRE 13580
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-kxannualsharehol_htm.xml XML 4170
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 20946419
SIC: 2836 Biological Products, (No Diagnostic Substances)